View of Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial | Acta Oncologica

Return to Article Details Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial